- Home
- Publications
- Publication Search
- Publication Details
Title
Evolving AAV-delivered therapeutics towards ultimate cures
Authors
Keywords
-
Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-19
DOI
10.1007/s00109-020-02034-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Versatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9
- (2020) Daniel Agudelo et al. GENOME RESEARCH
- The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations
- (2020) Jingyi Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Interim results of Transpher A, a multicenter, single-dose, phase 1/2 clinical trial of ABO-102 gene therapy for Sanfilippo syndrome type A (mucopolysaccharidosis type IIIA)
- (2020) Kevin M. Flanigan et al. MOLECULAR GENETICS AND METABOLISM
- Treatment of a Mouse Model of ALS by In Vivo Base Editing
- (2020) Colin K.W. Lim et al. MOLECULAR THERAPY
- AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
- (2020) Helena Costa Verdera et al. MOLECULAR THERAPY
- Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy
- (2020) A. Moretti et al. NATURE MEDICINE
- Engineering adeno-associated virus vectors for gene therapy
- (2020) Chengwen Li et al. NATURE REVIEWS GENETICS
- Capsid-specific removal of circulating antibodies to adeno-associated virus vectors
- (2020) Berangere Bertin et al. Scientific Reports
- CRISPR/Cas Systems in Genome Editing: Methodologies and Tools for sgRNA Design, Off‐Target Evaluation, and Strategies to Mitigate Off‐Target Effects
- (2020) Hakim Manghwar et al. Advanced Science
- Successful Transduction with AAV Vectors after Selective Depletion of Anti-AAV Antibodies by Immunoadsorption
- (2020) Alejandro Orlowski et al. Molecular Therapy-Methods & Clinical Development
- Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system
- (2020) Yu Zhang et al. Science Advances
- Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses
- (2020) Jonathan M. Levy et al. Nature Biomedical Engineering
- CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
- (2020) Dan Wang et al. CELL
- One Small Dose, One Giant Leap for CRISPR Gene Editing
- (2020) Alex Philippidis HUMAN GENE THERAPY
- A Highly Efficacious PS Gene Editing System Corrects Metabolic and Neurological Complications of Mucopolysaccharidosis Type I
- (2020) Li Ou et al. MOLECULAR THERAPY
- Amelioration of an Inherited Metabolic Liver Disease through Creation of a De Novo Start Codon by Cytidine Base Editing
- (2020) Lei Yang et al. MOLECULAR THERAPY
- CRISPR system: Discovery, development and off-target detection
- (2020) Shengmiao Chen et al. CELLULAR SIGNALLING
- Moving Forward After Two Deaths in a Gene Therapy Trial of Myotubular Myopathy
- (2020) James M. Wilson et al. HUMAN GENE THERAPY
- Pfizer and Sangamo Hemophilia A Gene Therapy Aces First Clinical Test
- (2020) Alex Philippidis HUMAN GENE THERAPY
- Factors Impacting Efficacy of AAV-Mediated CRISPR-Based Genome Editing for Treatment of Choroidal Neovascularization
- (2020) Sook Hyun Chung et al. Molecular Therapy-Methods & Clinical Development
- Activity of Transgene-Produced B-Domain Deleted Factor VIII in Human Plasma Following AAV5 Gene Therapy
- (2020) Steffen Rosen et al. BLOOD
- Gene therapy and gene correction: targets, progress, and challenges for treating human diseases
- (2020) Matthew R. Cring et al. GENE THERAPY
- SMA – THERAPY
- (2020) E. Mercuri et al. NEUROMUSCULAR DISORDERS
- SMA – THERAPY
- (2020) D. Chand et al. NEUROMUSCULAR DISORDERS
- Specter of eye toxicity looms over BCMA-targeted therapy
- (2020) Elie Dolgin NATURE BIOTECHNOLOGY
- Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia
- (2019) Sarah Marktel et al. NATURE MEDICINE
- Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10
- (2019) Morgan L. Maeder et al. NATURE MEDICINE
- Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors
- (2019) Hildegard Büning et al. Molecular Therapy-Methods & Clinical Development
- Adeno-associated virus vector as a platform for gene therapy delivery
- (2019) Dan Wang et al. NATURE REVIEWS DRUG DISCOVERY
- One-step generation of modular CAR-T cells with AAV–Cpf1
- (2019) Xiaoyun Dai et al. NATURE METHODS
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
- (2019) Christopher E. Nelson et al. NATURE MEDICINE
- An evolutionary approach to optimizing glucose-6-phosphatase-α enzymatic activity for gene therapy of glycogen storage disease type Ia
- (2019) Lisa Zhang et al. JOURNAL OF INHERITED METABOLIC DISEASE
- CRISPR/Cas9-mediated in vivo gene targeting corrects hemostasis in newborn and adult factor IX knockout mice
- (2019) Lili Wang et al. BLOOD
- Prevention of cholestatic liver disease and reduced tumorigenicity in a murine model of PFIC type 3 using hybrid AAV‐ piggyBac gene therapy
- (2019) S.M Siew et al. HEPATOLOGY
- Life-Long AAV-Mediated CRISPR Genome Editing in Dystrophic Heart Improves Cardiomyopathy without Causing Serious Lesions in mdx Mice
- (2019) Li Xu et al. MOLECULAR THERAPY
- The next generation of CRISPR–Cas technologies and applications
- (2019) Adrian Pickar-Oliver et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina
- (2019) Patrizia Tornabene et al. Science Translational Medicine
- Novel AAV-mediated gene delivery system corrects CFTR function in pigs
- (2019) Ashley L. Cooney et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- AAV9 Vector: a Novel modality in gene therapy for spinal muscular atrophy
- (2019) Rithu Pattali et al. GENE THERAPY
- Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss
- (2019) Bence György et al. NATURE MEDICINE
- FDA new drug approvals in Q2 2019
- (2019) Lisa Urquhart NATURE REVIEWS DRUG DISCOVERY
- Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials
- (2019) Albert M. Maguire et al. OPHTHALMOLOGY
- Gene correction for SCID-X1 in long-term hematopoietic stem cells
- (2019) Mara Pavel-Dinu et al. Nature Communications
- Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice
- (2019) Prasanta K. Dash et al. Nature Communications
- Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics
- (2019) Jayesh A. Kulkarni et al. ACCOUNTS OF CHEMICAL RESEARCH
- dCas9-based Scn1a gene activation restores inhibitory interneuron excitability and attenuates seizures in Dravet syndrome mice
- (2019) Gaia Colasante et al. MOLECULAR THERAPY
- CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia
- (2019) Lei Xu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rationally engineered Staphylococcus aureus Cas9 nucleases with high genome-wide specificity
- (2019) Yuanyan Tan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors
- (2019) Anita Kruzik et al. Molecular Therapy-Methods & Clinical Development
- Clinical Considerations for Capsid Choice in the Development of Liver-Targeted AAV-Based Gene Transfer
- (2019) Steven Pipe et al. Molecular Therapy-Methods & Clinical Development
- In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia
- (2019) Huan Zhao et al. CIRCULATION
- A Molecular Revolution in the Treatment of Hemophilia
- (2019) John S.S. Butterfield et al. MOLECULAR THERAPY
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- High levels of AAV vector integration into CRISPR-induced DNA breaks
- (2019) Killian S. Hanlon et al. Nature Communications
- Hemophilia A ameliorated in mice by CRISPR-based in vivo genome editing of human Factor VIII
- (2019) Hainan Chen et al. Scientific Reports
- Applications and explorations of CRISPR/Cas9 in CAR T-cell therapy
- (2019) Chenggong Li et al. Briefings in Functional Genomics
- Gene therapy for hemophilia
- (2019) Amit C. Nathwani Hematology-American Society of Hematology Education Program
- AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria
- (2019) Daelyn Y. Richards et al. Molecular Therapy-Methods & Clinical Development
- Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus
- (2018) Chiara Antoniani et al. BLOOD
- A CRISPR-Cas13a system for efficient and specific therapeutic targeting of mutant KRAS for pancreatic cancer treatment
- (2018) Xiao Zhao et al. CANCER LETTERS
- Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors
- (2018) Silvana Konermann et al. CELL
- In Vivo Selection of a Computationally Designed SCHEMA AAV Library Yields a Novel Variant for Infection of Adult Neural Stem Cells in the SVZ
- (2018) David S. Ojala et al. MOLECULAR THERAPY
- Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy
- (2018) Seuk-Min Ryu et al. NATURE BIOTECHNOLOGY
- Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding
- (2018) Gabriella E. Martyn et al. NATURE GENETICS
- CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
- (2018) Taeyoung Koo et al. Nature Communications
- RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors
- (2018) Pratiksha I. Thakore et al. Nature Communications
- Cas9-mediated allelic exchange repairs compound heterozygous recessive mutations in mice
- (2018) Dan Wang et al. NATURE BIOTECHNOLOGY
- Gene therapy for neurological disorders: progress and prospects
- (2018) Benjamin E. Deverman et al. NATURE REVIEWS DRUG DISCOVERY
- Gene therapy for visual loss: Opportunities and concerns
- (2018) Jia Hui Lee et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Non-Viral Delivery To Enable Genome Editing
- (2018) Yuan Rui et al. TRENDS IN BIOTECHNOLOGY
- Cas9 immunity creates challenges for CRISPR gene editing therapies
- (2018) Julie M. Crudele et al. Nature Communications
- Update on clinical gene therapy for hemophilia
- (2018) George Q. Perrin et al. BLOOD
- Homology-independent multiallelic disruption via CRISPR/Cas9-based knock-in yields distinct functional outcomes in human cells
- (2018) Chenzi Zhang et al. BMC BIOLOGY
- Infectivity of adeno-associated virus serotypes in mouse testis
- (2018) Santhanasabapathy Rajasekaran et al. BMC BIOTECHNOLOGY
- Somatic Gene Editing of GUCY2D by AAV-CRISPR/Cas9 Alters Retinal Structure and Function in Mouse and Macaque
- (2018) K. Tyler McCullough et al. HUMAN GENE THERAPY
- High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
- (2018) Dimitrios L. Wagner et al. NATURE MEDICINE
- Treatment of a metabolic liver disease by in vivo genome base editing in adult mice
- (2018) Lukas Villiger et al. NATURE MEDICINE
- In utero CRISPR-mediated therapeutic editing of metabolic genes
- (2018) Avery C. Rossidis et al. NATURE MEDICINE
- Health outcomes in spinal muscular atrophy type 1 following AVXS‐101 gene replacement therapy
- (2018) Samiah Al‐Zaidy et al. PEDIATRIC PULMONOLOGY
- Cas9/sgRNA selective targeting of the P23H Rhodopsin mutant allele for treating retinitis pigmentosa by intravitreal AAV9.PHP.B-based delivery
- (2017) Serena G Giannelli et al. HUMAN MOLECULAR GENETICS
- CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo
- (2017) Lei Xu et al. MOLECULAR THERAPY
- CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10
- (2017) Guo-Xiang Ruan et al. MOLECULAR THERAPY
- In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models
- (2017) Chaoran Yin et al. MOLECULAR THERAPY
- Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
- (2017) Justin Eyquem et al. NATURE
- RNA targeting with CRISPR–Cas13
- (2017) Omar O. Abudayyeh et al. NATURE
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
- (2017) Nicole M. Gaudelli et al. NATURE
- Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism
- (2017) Dwi U Kemaladewi et al. NATURE MEDICINE
- Mapping the genomic landscape of CRISPR–Cas9 cleavage
- (2017) Peter Cameron et al. NATURE METHODS
- CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR–Cas9 nuclease off-targets
- (2017) Shengdar Q Tsai et al. NATURE METHODS
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
- (2017) Lindsey A. George et al. NEW ENGLAND JOURNAL OF MEDICINE
- AAV5–Factor VIII Gene Transfer in Severe Hemophilia A
- (2017) Savita Rangarajan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Therapy with the Sleeping Beauty Transposon System
- (2017) Partow Kebriaei et al. TRENDS IN GENETICS
- In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
- (2017) Eunji Kim et al. Nature Communications
- CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice
- (2017) Tsukasa Ohmori et al. Scientific Reports
- CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors
- (2017) Rasmus O. Bak et al. Cell Reports
- CAR T-Cell Therapy: Progress and Prospects
- (2017) Olivia Wilkins et al. Human Gene Therapy Methods
- Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape
- (2017) Federico Mingozzi et al. Annual Review of Virology
- Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
- (2017) Kunwoo Lee et al. Nature Biomedical Engineering
- Genome editing with CRISPR/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome
- (2016) Chang Xie et al. CELL RESEARCH
- Adeno-Associated Virus Gene Therapy for Liver Disease
- (2016) Lisa M. Kattenhorn et al. HUMAN GENE THERAPY
- Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
- (2016) Partow Kebriaei et al. JOURNAL OF CLINICAL INVESTIGATION
- 731. High-Fidelity CRISPR-Cas9 Nucleases with No Detectable Genome-Wide Off-Target Effects
- (2016) Benjamin P. Kleinstiver et al. MOLECULAR THERAPY
- Recombinant AAV Integration Is Not Associated With Hepatic Genotoxicity in Nonhuman Primates and Patients
- (2016) Irene Gil-Farina et al. MOLECULAR THERAPY
- In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
- (2016) Keiichiro Suzuki et al. NATURE
- CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
- (2016) Daniel P. Dever et al. NATURE
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice
- (2016) Yang Yang et al. NATURE BIOTECHNOLOGY
- Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
- (2016) Hao Yin et al. NATURE BIOTECHNOLOGY
- A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition
- (2016) Elizabeth A Traxler et al. NATURE MEDICINE
- A multifunctional AAV–CRISPR–Cas9 and its host response
- (2016) Wei Leong Chew et al. NATURE METHODS
- Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair
- (2016) Xiangjun He et al. NUCLEIC ACIDS RESEARCH
- Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia
- (2016) Lin Ye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
- (2016) Omar O. Abudayyeh et al. SCIENCE
- Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
- (2016) M. A. DeWitt et al. Science Translational Medicine
- Adeno-Associated Virus 2-Mediated Hepatocellular Carcinoma is Very Rare in Korean Patients
- (2016) Kyoung-Jin Park et al. Annals of Laboratory Medicine
- In vivo tissue-tropism of adeno-associated viral vectors
- (2016) Arun Srivastava Current Opinion in Virology
- Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells
- (2016) David L DiGiusto et al. Molecular Therapy-Methods & Clinical Development
- Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases
- (2016) Diane Yang et al. Scientific Reports
- Viral Vectors for Gene Therapy: Translational and Clinical Outlook
- (2015) Melissa A. Kotterman et al. Annual Review of Biomedical Engineering
- In vivo genome editing of the albumin locus as a platform for protein replacement therapy
- (2015) R. Sharma et al. BLOOD
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
- (2015) Bernd Zetsche et al. CELL
- Alipogene Tiparvovec: A Review of Its Use in Adults with Familial Lipoprotein Lipase Deficiency
- (2015) Lesley J. Scott DRUGS
- Modeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno-associated virus/piggyBactransposase gene delivery system
- (2015) Sharon C. Cunningham et al. HEPATOLOGY
- Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?
- (2015) Kenneth I. Berns et al. HUMAN GENE THERAPY
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
- (2015) Jianbin Wang et al. NATURE BIOTECHNOLOGY
- Therapeutic genome editing: prospects and challenges
- (2015) David Benjamin Turitz Cox et al. NATURE MEDICINE
- Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells
- (2015) Daesik Kim et al. NATURE METHODS
- Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements
- (2015) Pratiksha I Thakore et al. NATURE METHODS
- A prudent path forward for genomic engineering and germline gene modification
- (2015) D. Baltimore et al. SCIENCE
- Rationally engineered Cas9 nucleases with improved specificity
- (2015) I. M. Slaymaker et al. SCIENCE
- Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
- (2015) C. Long et al. SCIENCE
- In vivo gene editing in dystrophic mouse muscle and muscle stem cells
- (2015) M. Tabebordbar et al. SCIENCE
- In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
- (2015) C. E. Nelson et al. SCIENCE
- AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
- (2015) Daniel J Hui et al. Molecular Therapy-Methods & Clinical Development
- Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
- (2014) Luke A. Gilbert et al. CELL
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- Basic Biology of Adeno-Associated Virus (AAV) Vectors Used in Gene Therapy
- (2014) Balaji Balakrishnan et al. CURRENT GENE THERAPY
- Targeted genome editing in human repopulating haematopoietic stem cells
- (2014) Pietro Genovese et al. NATURE
- In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9
- (2014) Lukasz Swiech et al. NATURE BIOTECHNOLOGY
- GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
- (2014) Shengdar Q Tsai et al. NATURE BIOTECHNOLOGY
- Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
- (2014) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors
- (2014) Jiabiao Hu et al. NUCLEIC ACIDS RESEARCH
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- AAV-Mediated Gene Therapy for Research and Therapeutic Purposes
- (2014) R. Jude Samulski et al. Annual Review of Virology
- Robust ZFN-mediated genome editing in adult hemophilic mice
- (2013) X. M. Anguela et al. BLOOD
- Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant
- (2013) J. McIntosh et al. BLOOD
- One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
- (2013) Haoyi Wang et al. CELL
- One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR/Cas-Mediated Genome Engineering
- (2013) Hui Yang et al. CELL
- Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair
- (2013) T. O. Auer et al. GENOME RESEARCH
- Recombinant AAV as a Platform for Translating the Therapeutic Potential of RNA Interference
- (2013) Florie Borel et al. MOLECULAR THERAPY
- CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering
- (2013) Prashant Mali et al. NATURE BIOTECHNOLOGY
- A largely random AAV integration profile after LPLD gene therapy
- (2013) Christine Kaeppel et al. NATURE MEDICINE
- Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing
- (2013) Nicola Crosetto et al. NATURE METHODS
- Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome
- (2013) A. Aiuti et al. SCIENCE
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Humoral Immune Response to AAV
- (2013) Roberto Calcedo et al. Frontiers in Immunology
- Single Amino Acid Modification of Adeno-Associated Virus Capsid Changes Transduction and Humoral Immune Profiles
- (2012) C. Li et al. JOURNAL OF VIROLOGY
- Endgame: Glybera Finally Recommended for Approval as the First Gene Therapy Drug in the European Union
- (2012) Seppo Ylä-Herttuala MOLECULAR THERAPY
- FLASH assembly of TALENs for high-throughput genome editing
- (2012) Deepak Reyon et al. NATURE BIOTECHNOLOGY
- Induction of hepatocellular carcinoma by in vivo gene targeting
- (2012) P.-R. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- CRISPR-Cas Systems in Bacteria and Archaea: Versatile Small RNAs for Adaptive Defense and Regulation
- (2011) Devaki Bhaya et al. Annual Review of Genetics
- Adeno-Associated Virus Antibody Profiles in Newborns, Children, and Adolescents
- (2011) Roberto Calcedo et al. Clinical and Vaccine Immunology
- Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia
- (2011) C Li et al. GENE THERAPY
- Novel Mini–Dystrophin Gene Dual Adeno-Associated Virus Vectors Restore Neuronal Nitric Oxide Synthase Expression at the Sarcolemma
- (2011) Yadong Zhang et al. HUMAN GENE THERAPY
- In vivo genome editing restores haemostasis in a mouse model of haemophilia
- (2011) Hojun Li et al. NATURE
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
- (2011) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway
- (2010) Michael R. Lieber Annual Review of Biochemistry
- Regulation of Homologous Recombination in Eukaryotes
- (2010) Wolf-Dietrich Heyer et al. Annual Review of Genetics
- Assessing the potential for AAV vector genotoxicity in a murine model
- (2010) H. Li et al. BLOOD
- Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
- (2010) Sylvie Boutin et al. HUMAN GENE THERAPY
- CEP290, a gene with many faces: mutation overview and presentation of CEP290base
- (2010) Frauke Coppieters et al. HUMAN MUTATION
- Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo
- (2010) Nathalia Holt et al. NATURE BIOTECHNOLOGY
- Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
- (2010) Kevin D Foust et al. NATURE BIOTECHNOLOGY
- Worldwide Epidemiology of Neutralizing Antibodies to Adeno‐Associated Viruses
- (2009) Roberto Calcedo et al. JOURNAL OF INFECTIOUS DISEASES
- Host and Vector-dependent Effects on the Risk of Germline Transmission of AAV Vectors
- (2009) Patricia Favaro et al. MOLECULAR THERAPY
- A Preclinical Animal Model to Assess the Effect of Pre-existing Immunity on AAV-mediated Gene Transfer
- (2009) Hua Li et al. MOLECULAR THERAPY
- Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy
- (2008) G. P. Niemeyer et al. BLOOD
- Protein Trans-Splicing as a Means for Viral Vector-Mediated In Vivo Gene Therapy
- (2008) Juan Li et al. HUMAN GENE THERAPY
- In Vitro and In Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated Viruses
- (2008) D. Grimm et al. JOURNAL OF VIROLOGY
- Rapid “Open-Source” Engineering of Customized Zinc-Finger Nucleases for Highly Efficient Gene Modification
- (2008) Morgan L. Maeder et al. MOLECULAR CELL
- Gene Delivery to the Juvenile Mouse Liver Using AAV2/8 Vectors
- (2008) Sharon C Cunningham et al. MOLECULAR THERAPY
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
- (2008) Kevin D Foust et al. NATURE BIOTECHNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More